MEDI9929 (AMG 157)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MEDI9929 (AMG 157), covering 2017-02-23 to 2018-12-04. Get the full timeline:
Most recent: Clinical Trial Update: Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma [Phase 2]